25 Jul 2024 --- Onego Bio has secured €14 million (US$15.2 million) in new EU and investor funding to commercialize its precision-fermentation-based egg protein “Bioalbumen” in North America. The ingredient is bioidentical to ovalbumin — the major protein in chicken egg white. The cash injection comes from the European Innovation Council (EIC) Accelerator Program and additional Series A investors, says the company.